Kitov Pharma appoints board member
Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Kitov Pharmaceuticals Holdings Ltd. appointed Arye Weber as a director to its board, effective Jan. 22.
Weber will serve as part of the first class of directors. Weber has been the chairman of the board and sole shareholder of Scorpio Investments Ltd., a private holding company for various investments, since 2001.